Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trialCameron R. Wolfe, Anabela Cardoso, Carlos A. Gómez et al.|The Lancet Respiratory Medicine|2022Cited by 128
The Respiratory Triple Pandemic in the Intensive Care UnitDaniel A. Sweeney, Andre Celestino Kalil, Xavier Wittebole|Critical Care Clinics|2026Cited by 0